17Mar 2023
Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia

Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia

The article discusses the impact of tyrosine kinase inhibitors (TKIs) on glucose dysregulation in patients with chronic myeloid leukemia (CML). Specifically, the study focuses on the effects of nilotinib on insulin secretion and sensitivity in skeletal muscle glucose uptake. The results show that patients with CML receiving nilotinib have increased insulin responses to glucose administration after muscle glycogen-depleted exercise, but slower glucose disappearance rates in the first 15 minutes after glucose administration. Additionally, patients receiving nilotinib showed a trend toward decreased glucose infusion rates during euglycemic clamping when compared with patients receiving imatinib, indicating disturbed skeletal muscle glucose handling. These findings suggest that TKI-induced hyperglycemia may increase cardiovascular disease risk in patients with CML.

  • #endo-diabetology

Like

Save

Share